| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c119bead5eed395d25518047fde63a66 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2015-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf4ce6476681180ecdd849ef1504de4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea483b21d76f3860b3cda447e5a09dfd |
| publicationDate |
2016-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160144663-A |
| titleOfInvention |
formulation and the method of prepareing thereof |
| abstract |
The present invention provides risedronate, a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof, and a preparation comprising vitamin D and a process for producing the same. The preparation according to the present invention contains a high content of the active ingredient and exhibits a high stability and excellent osteoporosis treatment effect. |
| priorityDate |
2015-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |